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2Abstract 
Most genetic variants identified in genome-wide association studies (GWAS) of complex traits are thought 
to act via effects on gene regulation rather than directly altering the protein product. As a consequence, the 
actual genes involved in disease are not necessarily the most proximal to the associated variants. By 
integrating data from GWAS analyses with that from genetic studies of regulatory variation, it is possible to 
identify variants pleiotropically-associated with both a complex trait and measures of gene regulation. In this 
study, we use Summary data–based Mendelian Randomization (SMR), a method developed to identify 
variants pleiotropically associated with both complex traits and gene expression, to identify variants that are 
associated with complex traits and DNA methylation. We use large DNA methylation quantitative trait loci 
(mQTL) datasets generated from two different tissues (blood and fetal brain) to prioritize genes for >40 
complex traits with robust GWAS data, highlighting considerable overlap with the results of SMR analyses 
performed using expression QTL (eQTL) data. We identify multiple examples of variable DNA methylation 
associated with GWAS variants for a range of complex traits, demonstrating the utility of this approach for 
refining genetic association signals.       
3There has been major progress in the identification of genetic variants influencing a diverse range of 
complex human phenotypes including anthropometric measures (e.g. height and weight)1; 2, cardiovascular 
disease3; 4, inflammatory disorders5, neurological diseases6; 7 and psychiatric illness8-10. The challenge is now 
to improve our understanding of the biological effects of these genetic risk factors, especially because the 
actual gene(s) involved in mediating phenotypic variation are not necessarily the most proximal to the lead 
SNPs identified in genome-wide association studies (GWAS). Supported by the observation that GWAS 
variants are preferentially located in enhancers and regions of open chromatin11; 12, the majority of common 
genetic risk factors are predicted to influence gene regulation rather than directly affecting the coding 
sequences of transcribed proteins13.   
Expression quantitative trait loci (eQTL) have been successfully used to investigate the functional 
consequences of GWAS variants14; 15. The co-localization of GWAS and eQTL variants, however, is not 
sufficient to show that the overlapping association signals are causally related, as the association signals may 
be tagging different causal variants in the same linkage disequilibrium (LD) block. Recently, an approach 
called Summary data–based Mendelian Randomization  (SMR) was proposed as a strategy for identifying 
overlapping genetic signals associated with both phenotypic and transcriptional variation, subsequently 
distinguishing pleiotropic effects - i.e. where the same variant is influencing both outcomes, although not 
necessarily dependently - from those that are an artefact of LD16. Genetic effects on gene expression can be 
mediated by epigenetic processes including changes in DNA methylation, a modification to cytosine that has 
an essential role in mammalian development17. We have previously demonstrated the utility of DNA 
methylation QTLs (mQTLs) for interpreting GWAS findings by identifying specific examples where genetic 
polymorphisms associated with schizophrenia [MIM: 181500] co-localize with variants associated with 
DNA methylation18; 19. In this study we apply the SMR approach to test 35,263 DNA methylation sites 
against 43 complex phenotypes with robust GWAS data (Table S1) using mQTLs identified in our recent 
analysis of methylomic variation in whole blood and imputed single nucleotide polymorphism (SNP) 
genotypes (n = 639; mQTL P < 1x10-10; a full description of this dataset, referred to as Phase 1, can be found 
here19) in conjunction with publicly-available summary data from a series of well-powered GWAS analyses. 
4The first stage of the SMR analysis identifies the most significantly associated SNP for a DNA methylation 
site (that is also present in the GWAS dataset) as an instrumental variable to test for an association with a 
phenotype by using the two-step least squares (2SLS) approach comparing the coefficients from the mQTL 
with those from a GWAS of the phenotype using the same SNP (Figure S1a). This approach identified 1,932 
associations (P < 1.42x10-6 corrected for 35,263 DNA methylation sites) between 31 complex traits and 
1,354 individual DNA methylation sites (Table S2 and Figure S2). Because these associations may be 
driven by two highly-correlated but different causal variants for the GWAS trait and DNA methylation, the 
second stage of the SMR approach repeats the analysis with alternative SNPs associated with DNA 
methylation as the instrument and performs a heterogeneity in dependent instruments (HEIDI) test for 
heterogeneity in the resulting association statistics. If there is a single causal variant associated with both 
phenotype and DNA methylation, the association statistics will be identical regardless of the selected 
instrument (Figure S1b) and the HEIDI P-value will be non-significant. In contrast, if there are two separate 
causal variants, each correlated with the instrument, there will be variation in the results from different 
instruments (Figure S1c) indicated by a significant HEIDI P-value.  It should be noted that this approach is 
unable to distinguish these two scenarios if the two causal variants are in perfect LD, with power inversely 
proportional to the strength of the correlation between the two causal variants. Furthermore, the assumptions 
underlying Mendelian Randomization 20 also apply to SMR, and it is possible that variants may act through 
mechanisms such as horizontal pleiotropy. 
By identifying non-significant heterogeneity (HEIDI P > 0.05), we identified a refined set of 625 
associations between 28 complex traits and 440 DNA methylation sites (Table S2), which can be described 
as pleiotropic. We were able to test 581 of these associations with mQTL generated from a second 
independent whole blood dataset (n = 665; a description of this cohort, referred to as Phase 2, can be found 
here19). A highly significant proportion (99.2%; sign test P = 1.47x10-172) had the same direction of 
association across the two datasets (Figure S3) with a large proportion (n = 337; 58.0%) satisfying the 
criteria for a pleiotropic association (P < 1.04x10-6 and HEIDI P > 0.05) in the replication dataset also. Out 
of the GWAS traits tested, height is characterized by the most associations (n = 193), an unsurprising 
5observation given that is the most highly-powered GWAS with the largest number of GWAS-significant loci 
(n = 423). Power for SMR analysis is influenced by the power of the GWAS, which differs for each trait 
considered, making comparisons between traits relatively difficult.   
As demonstrated in its original implementation for eQTLs, the SMR approach based on mQTLs has the 
potential to nominate loci that currently do not have sufficient statistical power to obtain genome-wide 
significance based on the GWAS data alone but which represent candidates for future genetic studies (Table 
S3). Our SMR analysis of Tanner staging of puberty, for example, identified DNA methylation sites in nine 
independent loci (annotated to APEH[MIM:102645], SYNJ2[MIM:609410], IDO2[MIM:612129], 
PDZRN4[MIM: 609730], HTR2A[MIM: 182135], CTDP1[MIM: 604927], RAE1[MIM: 603343], and non-
genic regions on chromosome 4 and 16) that do not have a genome-wide significant (P < 5x10-8) variant 
within 0.5Mb in the GWAS21 (Figure S4). In some genomic regions, DNA methylation sites annotated to 
different genes are associated with the same phenotype; for example on chromosome 15, sites annotated to 
CHRNA5[MIM: 118505] and PSMA4[MIM: 176846] are associated with the number of cigarettes smoked 
per day (Figure S5), and on chromosome 17, sites annotated to ERBB2[MIM: 164870] and PGAP3[MIM: 
611801] are associated with total cholesterol (Figure S6). Furthermore, 130 DNA methylation sites were 
found to be associated with multiple complex traits (Table S4; range = 2 to 6 traits). In many cases these 
overlaps are consistent with either reported phenotypic correlations (e.g. cg24631222 and cg04140906 
annotated to CHRNA5 are associated with both schizophrenia and the number of cigarettes smoked per day 
(Figure S7), two traits that are epidemiologically linked22; 23) or shared genetic architecture (e.g. 
cg10583485, annotated to DOCK7[MIM: 615730] (Figure S8), is associated with LDL, triglycerides and 
total cholesterol, three traits characterized by a strong genetic correlation24). Because genetic correlations 
could account for some of the overlap between traits we factored in genetic correlations derived using LD 
Score regression24, showing that 30 out of the 70 pairs of traits with at least one associated DNA methylation 
site in common are actually characterized by a genetic correlation < 0.2 (Figure S9).  
Multiple DNA methylation sites can be annotated to a single gene, and in total we identified 337 gene-trait 
pleiotropic associations with a mean of 1.46 sites associated per gene (range = 1-11).  These overlapping 
6associations between a particular complex trait and a gene would not be expected to be associated in the 
same direction as correlation of DNA methylation across a gene is not always positive, and were not for 20 
out of the 31 gene–trait associations involving genes with multiple annotated DNA methylation sites. To add 
further support to the genes prioritised at GWAS loci using blood mQTL data, we aligned these results with 
SMR analyses performed on publically available whole blood eQTL data (n = 5,311; P < 5 × 10−8) described 
in detail in a recent paper by Westra and colleagues15. We identified an overlapping set of 2,724 genes that 
were i) annotated to DNA methylation sites influenced by significant mQTLs (involving 7,722 distinct DNA 
methylation sites) and ii) also transcriptionally influenced by variation at significant eQTLs (involving 2,770 
gene expression microarray probes), making them suitable for testing in the SMR framework. It should be 
noted that one limitation to assessing the relationship between mQTLs and eQTLs is that DNA methylation 
sites, like SNPs, are annotated to genes based on their location; therefore a lack of overlap in the associations 
with a particular gene from the SMR analyses of DNA methylation and gene expression should not 
necessarily be interpreted as inconsistent evidence. Furthermore, the differences in the sample sizes used to 
generate the mQTL and eQTL datasets may result in different statistical power to detect QTLs. 86 of the 337 
(25.5%) pleiotropic gene-trait associations identified with mQTLs were also tested with eQTLs in the SMR 
framework (Figure S10). Of these 27 (31.4%) also meet the criteria to be defined as representing pleiotropic 
associations between the trait and gene expression (SMR P < 8.38x10-6 corrected for 5,966 gene expression 
probes and HEIDI P > 0.05) involving 17 complex traits associated with expression at 16 genes (Table S5). 
An example of an overlapping mQTL and eQTL signal for RNASET2 [MIM: 612944] on chromosome 6 is 
presented in Figure 1; both RNASET2 expression (SMR P = 6.04x10-8) and DNA methylation at two CpG 
sites in the first intron of the gene (cg25258033: SMR P = 2.84x10-10; cg25258033: SMR P = 2.50x10-10) are 
associated with Crohn’s disease [MIM: 266600]. 
Given the tissue-specific and developmentally-dynamic nature of gene regulation we were next interested in 
examining the consistency of our findings in a different tissue, repeating the SMR analysis on mQTL 
identified in our recent analysis of human fetal brain (n = 166; mQTL P < 1x10-8; a detailed description of 
this dataset can be found here18). The majority (75.4%) of SNP-DNA methylation relationships identified for 
SMR analysis in whole blood are characterized by a consistent direction of effect when tested in fetal brain 
7(sign test P = 4.94x10-324; Figure S11). Despite the strong concordance of mQTL effects across tissues, the 
smaller number of samples used to generate the fetal brain dataset (n = 166) means that only a subset (4,691 
(13.3%)) of these mQTL associations passed our mQTL significance threshold (P < 1x10-8) and were 
included in the subsequent SMR analyses; almost all of these (96.0%; sign test P < 2.2x10-308) were 
characterized by the same direction of effect in both tissues (Figure S12). 84 (13.5%) of the 625 pleiotropic 
associations between identified with whole blood mQTLs involved a DNA methylation site that also had a 
significant fetal brain mQTL (P < 1x10-8)  meaning it could be tested with the SMR framework (Figure 
S13). 35 of these 84 (41.7%) pleiotropic associations met the criteria (i.e. SMR P < 5.40 x 10-6 corrected for 
9,265 DNA methylation sites tested and HEIDI P > 0.05) to be defined as also having a pleiotropic 
association in fetal brain involving9 complex traits (Table S6). While six (17.1%) of the site-trait 
associations involve brain-related phenotypes (5 for schizophrenia and 1 for migraine [MIM: 157300]), the 
majority (82.9%) involve traits which are presumed to affect other tissues (e.g. total cholesterol and Crohn’s 
disease), suggesting that effects are common across tissues. Figure 2 summarizes SMR analysis across the 
HEY2-NOCA7 region on chromosome 6 implicated in a recent GWAS of migraine25. Manhattan plots for the 
genetic analysis of cg05901451 located in the 5’UTR of HEY2 [MIM: 604674] in whole blood and fetal 
brain show a highly comparable profile to the GWAS of migraine, consistent with overlapping genetic 
signals influencing DNA methylation in both tissues and migraine 25. 
Finally, comparing the SMR results across multiple complex traits gives a potential insight into shared 
pleiotropic associations between pairs of traits. We performed hierarchical clustering of SMR results for 38 
complex traits, selected because they were tested against a minimum of 20,000 DNA methylation sites, to 
identify consistent signatures (Figure S14). Figure 3, for example, depicts the association statistics for 43 
DNA methylation sites associated with Crohn’s disease (SMR P < 1.42x10-6) across all 38 phenotypes; 
interestingly, we observe a highly concordant profile between Crohn’s disease and ulcerative colitis across 
all associated sites, consistent the strong genetic correlation between these traits (Figure S9); the SMR 
results may highlight which genes are characterized by shared effects between traits. There is also a notable 
overlap with BMI, waist and hip circumference at specific loci (i.e. ATP2A1[MIM: 108730], SULT1A2
8[MIM: 601292] and SBK1[MIM: 300374]), an interesting observation given the negligible genetic 
correlations between these traits and Crohn’s disease.  
Taken together, these analyses demonstrate the utility of the SMR approach for identifying instances where 
complex traits and variable DNA methylation are pleiotropically-associated with genetic variation. This 
approach may facilitate our understanding of the functional consequences of genetic risk variants for a range 
of complex traits and may facilitate the localization and prioritization of specific genes within genomic 
regions identified by GWAS.      
9Supplemental Data 
Supplemental Data include twelve figures and six tables and can be found with this article online at 
XXXXXXX. 
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Figure Legends 
Figure 1. Summary data–based Mendelian Randomization (SMR) analysis using quantitative trait loci 
associated with DNA methylation (mQTL) and gene expression (eQTL) implicates a role for RNASET2
in Crohn’s disease. Shown is a genomic region on chromosome 6 (hg19:167243095- 167565882) identified 
in a recent GWAS of Crohn’s disease performed by Liu et al.5. Genes located in this region are shown at the 
top, with exons indicated by thicker bars and the red arrows indicating the direction of transcription. DNA 
methylation sites interrogated by the Illumina 450K array are indicated by solid vertical lines underneath the 
genes. The four bottom panels depict the –log10 P value (y-axis) against genomic location (x-axis) from A)
SMR analysis (where squares represent Illumina 450K array DNA methylation sites and triangles represent 
gene expression probes, with green and red highlighting those with non-significant HEIDI test for DNA 
methylation and gene expression respectively), B) blood mQTL (n = 639) for the DNA methylation site 
cg25258033 (outlined in black in panel A), C) blood eQTL (n = 5,311) results for ILMN1671565 (outlined 
in black in panel A)), and D) the GWAS of Crohn’s disease performed by Liu et al.5.  
Figure 2. Summary data–based Mendelian Randomization (SMR) analysis using whole blood and fetal 
brain mQTL data implicates a role for the HEY2 locus in migraine. Shown is a genomic region on 
chromosome 6 (hg19: 125970800-126170800) identified in a recent GWAS of migraine performed by 
Gormley et al.25. Genes located in this region are shown at the top, with exons indicated by thicker bars and 
the red arrows indicating the direction of transcription. The four bottom panels depict the –log10 P value (y-
axis) against genomic location (x-axis) from A) SMR analysis (where points represent DNA methylation 
sites interrogated by the Illumina 450K array; black and grey indicates SMR tests from blood (squares) or 
fetal brain (diamonds) mQTL respectively with green squares and blue diamonds highlighting those with a 
non-significant HEIDI test for blood and fetal brain respectively), mQTL results for the DNA methylation 
site cg05901451 (outlined in black in panel A)) in B) blood (n = 639) and C) fetal brain (n = 166) and D) the 
GWAS of migraine performed by Gormley et al (n = 59,674 cases and 316,078 controls)25. 
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Figure 3. Heat-map of the SMR results for 32 DNA methylation sites associated with Crohn’s disease 
(SMR P < 1.38x10-6 and HEIDI P > 0.05) across 38 GWAS datasets. Each square in the heat-map 
represents the t-statistic (b_SMR/se_SMR) of the GWAS trait (columns) for a DNA methylation site (row; n 
= 32) associated with Crohn’s Disease. Only phenotypes (n = 38) tested against at least 20,000 DNA 
methylation sites were included in this comparison. 
Table S1. Details of all publically available GWAS results included in SMR analysis. 
Table S2. Results from SMR analysis for all significant associations (P < 1.42x10-6) between complex traits 
and DNA methylation.  
Table S3. Associations from SMR analysis where no SNP within 0.5Mb has obtained genome-wide 
significance (P < 5x10-8) in GWAS. These loci therefore represent associations worthy of further 
investigation for that complex trait. 
Table S4. Table of overlapping associations with specific DNA methylation sites between complex traits; 
entries above the diagonal detail the specific Illumina 450K array probe and entries below the diagonal detail 
the gene that probe is located within.  
Table S5. Table of gene-trait associations identified with SMR analysis using whole blood mQTL and blood 
eQTL. 
Table S6. Table of DNA methylation sites associated through mQTL identified in both whole blood and 
fetal brain. 
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